Stock listing
A3CRZT Stock Price, News, Filings & Events — Carvolix
Selected listing: A3CRZT · LSX · EUR · DE
This page tracks Carvolix's A3CRZT:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3CRZT:LSX. A3CRZT:LSX is the stock-level entry point for investors researching Carvolix, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A3CRZT:LSX
- Asset type
- Stock
- Market cap
- $423.5M
- Sector
- Technology Services
- Industry
- Packaged Software
- Exchange
- LSX
- Currency
- EUR
Carvolix A3CRZT:LSX stock context
This page tracks Carvolix's A3CRZT:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3CRZT:LSX. A3CRZT:LSX is the stock-level entry point for investors researching Carvolix, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Carvolix
Carvolix Takes a Key Step Toward Commercial Launch of TAVIPILOT Software in Europe with Regulatory Submission for CE Marking.
September 9, 2026
Carvolix Secures EUR 30 Million Of Structured Debt Financing To Fuel Its Growth.
August 6, 2026
Carvolix Secures New EUR 10m Tranche, Bringing Total Financing to EUR 20m as Part of its EUR 30m Programme
June 24, 2026
Carvolix announces positive 3-years clinical results for Kalios™ , the only adjustable mitral ring. 100% of patients met primary endpoint...
June 15, 2026
Carvolix Announces Positive Results of the Postmarketing Clinical Program Evaluating the TAVIPILOT AI Software.
May 4, 2026
Research Carvolix
Carvolix investor report
Review AI stock analysis and investor report context for A3CRZT:LSX.
Carvolix company profile
View the public company page for Carvolix on 6ix.
Carvolix news
Read company news and market updates connected to Carvolix.
Carvolix investor events
Find investor webinars, events, and replay context for Carvolix.
Alternate listings
CVX:EURONEXT
FR · EUR
Alternate listing for Carvolix; the primary context on this page is A3CRZT:LSX.
0JZ:GETTEX
DE · EUR
Alternate listing for Carvolix; the primary context on this page is A3CRZT:LSX.
A3CRZT:LS
DE · EUR
Alternate listing for Carvolix; the primary context on this page is A3CRZT:LSX.
CVXP:AQUISEU
GB · EUR
Alternate listing for Carvolix; the primary context on this page is A3CRZT:LSX.
CVXP:AQUISUK
GB · EUR
Alternate listing for Carvolix; the primary context on this page is A3CRZT:LSX.
0JZ:FWB
DE · EUR
Alternate listing for Carvolix; the primary context on this page is A3CRZT:LSX.
0JZ:MUN
DE · EUR
Alternate listing for Carvolix; the primary context on this page is A3CRZT:LSX.
0JZ:SWB
DE · EUR
Alternate listing for Carvolix; the primary context on this page is A3CRZT:LSX.